U.S. Markets open in 4 hrs 56 mins

Lotus Pharmaceutical Co., Ltd. (1795.TW)

Taiwan - Taiwan Delayed Price. Currency in TWD
233.50-13.00 (-5.27%)
At close: 01:30PM CST

Lotus Pharmaceutical Co., Ltd.

No. 277 Song Ren Road
17th Floor Xin Yi District
Taipei 110
886 2 2700 5908

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Petar Antonov VazharovGM & Director34.72MN/AN/A
Mr. Zenon ZdunekVP of Supply Chain & Operations12.83MN/AN/A
Mr. Bjartur ShenVP / Deputy Gen. Mang. of Strategy & Fin.21.05MN/AN/A
Ms. Eeling ChanChief Financial OfficerN/AN/AN/A
Angela LuanCorp. Fin. & Regional Investor Relations DirectorN/AN/AN/A
Ms. Hsieh GwenChief Information OfficerN/AN/AN/A
Dr. Saral ThangamChief Exec. Officer of Norwich Clicial ServicesN/AN/AN/A
Mr. Stanley GuCountry Mang.N/AN/AN/A
Mr. Yao Le HongVPN/AN/AN/A
Mr. Charles LinStrategic ConsultantN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.


Lotus Pharmaceutical Co., Ltd. research, develops, manufactures, and sells generic pharmaceutical products in Taiwan, Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system disease. The company also sells and markets a portfolio of over-the-counter medicines. In addition, it engages in wholesale of cosmetics; retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. Further, the company offers pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan. Lotus Pharmaceutical Co., Ltd. is a subsidiary of Alvogen Emerging Markets Holdings Limited.

Corporate Governance

Lotus Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.